By integrating proteomic analysis with functional assays, we provide compelling evidence that DHHC9‐mediated STRN4 palmitoylation facilitates YAP nuclear localisation, thereby enhancing YAP/TAZ signalling and ultimately driving cancer cell migration. Here, STRN4 is linked to cancer.